<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30019" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Thallium-201</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Poudyal</surname>
            <given-names>Bhavya</given-names>
          </name>
          <aff>Kathmandu Medical College and Teaching Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shrestha</surname>
            <given-names>Pallabi</given-names>
          </name>
          <aff>Kathmandu Medical College and Teaching Hospital, Nepal</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chowdhury</surname>
            <given-names>Yuvraj S.</given-names>
          </name>
          <aff>State University of New York - Downstate</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bhavya Poudyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pallabi Shrestha declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yuvraj Chowdhury declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30019.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Thallium-201 is a radiopharmaceutical agent used in the diagnosis of coronary artery disease and parathyroid hyperactivity. Other useful applications for a thallium-201 scan, like tumor diagnosis and olfacto-scintigraphy, are being explored and have shown promising results in various studies. This activity reviews the indications, mechanism of action, administration, adverse effects, monitoring, toxicity, and enhancement of health care outcomes for Thallium-201 as a valuable diagnostic agent in the clinical setting as pertinent for members of the interprofessional team in the evaluation and diagnosis of coronary artery disease and related conditions in patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the mechanism of action of thallium-201.</p></list-item><list-item><p>Describe the potential adverse effects of thallium-201.</p></list-item><list-item><p>Review the possibility of toxicity with thallium-201.</p></list-item><list-item><p>Outline the importance of collaboration and communication amongst the interprofessional team to enhance care coordination for patients receiving thallium-201 for scintigraphy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30019&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30019">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30019.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Thallium-201 is an isotope of the element thallium, which has been accepted by the Food and Drug Administration (FDA) for use as a radiopharmaceutical in nuclear medicine scans.<xref ref-type="bibr" rid="article-30019.r1">[1]</xref>&#x000a0;Indications&#x000a0;for the thallium-201 scan are as follows:</p>
        <p>
<bold>FDA Approved Indications</bold>
</p>
        <p>Myocardial imaging: One of its principal uses is in myocardial imaging. It can help to differentiate between ischemic and infarcted myocardium by comparing the scans at rest and stress (exercise or pharmacological stress). Ischemic myocardium shows decreased uptake only at stress, whereas infarcted/scarred myocardium shows fixed defects present at rest as well as stress.&#x000a0;<xref ref-type="bibr" rid="article-30019.r2">[2]</xref> Thallium-201 myocardial perfusion scan is especially very useful in the following:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Diagnosis of symptomatic and asymptomatic coronary artery disease.<xref ref-type="bibr" rid="article-30019.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Screening of non-specific results on the exercise EKG test.<xref ref-type="bibr" rid="article-30019.r2">[2]</xref></p>
          </list-item>
          <list-item>
            <p>Determination of risk before non-cardiac surgery.<xref ref-type="bibr" rid="article-30019.r3">[3]</xref>&#x000a0;There is a high risk of cardiac complications during vascular surgeries, like abdominal aortic aneurysm repair. Hence, ischemia, if shown by the scan, must be addressed before the surgery.<xref ref-type="bibr" rid="article-30019.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Determination of risk after an event of myocardial infarction.<xref ref-type="bibr" rid="article-30019.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Determination of risk before and after revascularization procedures.<xref ref-type="bibr" rid="article-30019.r5">[5]</xref><xref ref-type="bibr" rid="article-30019.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>In addition to evaluating myocardial perfusion, thallium-201 has an additional advantage over other nuclear scans in its property of redistribution, so it can also assess the viability of the myocardium, thus separating ischemic myocardium from scar tissue.<xref ref-type="bibr" rid="article-30019.r6">[6]</xref><xref ref-type="bibr" rid="article-30019.r1">[1]</xref><xref ref-type="bibr" rid="article-30019.r7">[7]</xref>&#x000a0;In contrast to normal myocardial cells, poorly perfused areas show reduced uptake and slow clearance.<xref ref-type="bibr" rid="article-30019.r8">[8]</xref></p>
        <p>Parathyroid imaging: Thallium-201 has been used in parathyroid imaging in patients with hyperplasias and adenomas.<xref ref-type="bibr" rid="article-30019.r9">[9]</xref><xref ref-type="bibr" rid="article-30019.r10">[10]</xref>&#x000a0;Studies show that thallium-201 can be used in addition to USG for parathyroid imaging prior to surgery.<xref ref-type="bibr" rid="article-30019.r11">[11]</xref><xref ref-type="bibr" rid="article-30019.r12">[12]</xref>&#x000a0;However, technetium (Tc) based scintigraphy is superior to thallium-201 for imaging parathyroid abnormalities.<xref ref-type="bibr" rid="article-30019.r13">[13]</xref><xref ref-type="bibr" rid="article-30019.r14">[14]</xref></p>
        <p>
<bold>Non-FDA Approved Indications</bold>
</p>
        <p>Primary CNS lymphoma (PCNSL): Thallium-201 is useful in distinguishing toxoplasmosis from PCNSL in HIV patients. In current practice, HIV patients with intracranial masses are treated empirically for toxoplasmosis; this increases mortality and morbidity due to delay in diagnosis and treatment. Thallium-201 is collected in tumor cells but not normal or dead cells; thus, it helps diagnose PCNSL. There has been a proposal that the thallium-201 SPECT (single-photon emission computerized tomography)&#x000a0;scan in conjunction with cerebrospinal fluid PCR for EBV (Epstein-Barr virus) be used to diagnose PCNSL to initiate empiric radiotherapy.<xref ref-type="bibr" rid="article-30019.r15">[15]</xref><xref ref-type="bibr" rid="article-30019.r16">[16]</xref>&#x000a0;However, thallium-201 alone in the diagnosis of PCNSL is not recommended.<xref ref-type="bibr" rid="article-30019.r17">[17]</xref></p>
        <p>Pulmonary Kaposi sarcoma: Thallium-201 scintigraphy is useful to diagnose the Kaposi sarcoma of the lungs without mucocutaneous involvement, which is a challenging diagnosis. A positive&#x000a0;thallium-201 scan is&#x000a0;used in conjunction with a negative gallium scan to make the diagnosis.<xref ref-type="bibr" rid="article-30019.r18">[18]</xref><xref ref-type="bibr" rid="article-30019.r19">[19]</xref></p>
        <p>Neoplasms: Thallium-201 is also very useful in diagnosing various tumors of the body, including pulmonary, thyroid, lymphomas, and breast.&#x000a0; Other uses include estimating the response of solid tumors like osteosarcoma to chemotherapy.<xref ref-type="bibr" rid="article-30019.r20">[20]</xref> It has also been useful in the diagnosis of pediatric brain and soft tissue neoplasms.<xref ref-type="bibr" rid="article-30019.r21">[21]</xref><xref ref-type="bibr" rid="article-30019.r22">[22]</xref></p>
        <p>Olfacto-scintigraphy: Thallium-201 administered via nasal route can be additionally used to image and assess the integrity of the olfactory pathway, which can be useful in patients with reduced olfaction or&#x000a0;following head trauma.<xref ref-type="bibr" rid="article-30019.r23">[23]</xref><xref ref-type="bibr" rid="article-30019.r24">[24]</xref><xref ref-type="bibr" rid="article-30019.r25">[25]</xref><xref ref-type="bibr" rid="article-30019.r26">[26]</xref></p>
        <p>Thyroid imaging: In some studies of patients with toxic goiter, thallium-201 proved to be a useful diagnostic tool to view the normal surrounding thyroid&#x000a0;cells,&#x000a0;which was not possible with other imaging modalities like Tc-99m and I-123.<xref ref-type="bibr" rid="article-30019.r27">[27]</xref><xref ref-type="bibr" rid="article-30019.r28">[28]</xref></p>
      </sec>
      <sec id="article-30019.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Thallium-201 is analogous to potassium in structure and uses the sodium-potassium pumps to get into cells of various organs.<xref ref-type="bibr" rid="article-30019.r2">[2]</xref> It has a half-life of about 73 hours and decays to mercury-201, releasing low energy gamma rays and X-rays, making it a useful radiopharmaceutical for scintigraphy.<xref ref-type="bibr" rid="article-30019.r29">[29]</xref><xref ref-type="bibr" rid="article-30019.r30">[30]</xref> Thallium-201 is taken up in the myocytes in about 5 to 15 minutes after injection. It is cleared out from the body via the kidneys,&#x000a0;thus reducing the artifacts in the bowel and gallbladder usually present in other myocardial scans.<xref ref-type="bibr" rid="article-30019.r30">[30]</xref><xref ref-type="bibr" rid="article-30019.r31">[31]</xref> These pharmacokinetic properties of thallium-201 make it suitable for myocardial perfusion imaging (MPI). In contrast to normally perfused myocardial cells, ischemic cells show delayed uptake. Thus the initial images help assess the perfusion, while the delayed images help evaluate the viability of the myocardium.<xref ref-type="bibr" rid="article-30019.r32">[32]</xref></p>
      </sec>
      <sec id="article-30019.s4" sec-type="Administration">
        <title>Administration</title>
        <p>Different imaging protocols are available for thallium-201 based myocardial perfusion imaging. The more common stress-rest protocols begin with stress imaging 15 minutes after injection of thallium-201, followed by rest imaging after 2.5&#x000a0;to 4 hours, and finally a redistribution imaging 24 hours later.<xref ref-type="bibr" rid="article-30019.r30">[30]</xref>&#x000a0;While the best protocol is not yet established, it should be selected and administered according to individual patient characteristics and habitus, associated medical conditions, and indications for the study. However, there is a common consensus that the dual-isotope scan that uses both thallium-201 and Tc-99m is not recommended.<xref ref-type="bibr" rid="article-30019.r30">[30]</xref><xref ref-type="bibr" rid="article-30019.r6">[6]</xref></p>
        <p>Dosing for MPI: In all MPI protocols, the American Society of Nuclear Cardiology recommends 2.5 to 3.5 mCi of thallium-201 for the initial dose (stress or rest imaging), while for the reinjections, if required in the protocol, an additional dose of 1 to 2 mCi of thallium-201 is recommended.<xref ref-type="bibr" rid="article-30019.r30">[30]</xref>&#x000a0;The 2020 Brazilian guideline advocates avoiding the use of doses higher than 3.5 mCi to reduce radiation exposure.<xref ref-type="bibr" rid="article-30019.r6">[6]</xref> In all cases, the dosage must be adjusted according to the patient's body mass index.<xref ref-type="bibr" rid="article-30019.r33">[33]</xref><xref ref-type="bibr" rid="article-30019.r34">[34]</xref><xref ref-type="bibr" rid="article-30019.r30">[30]</xref>&#x000a0;In a study, Bednarova et al. proposed using ultra-low-dose thallium-201 (0.014mCi/kg body weight) with CZT (cadmium-zinc-telluride) SPECT technology for MPI, which seems promising.<xref ref-type="bibr" rid="article-30019.r31">[31]</xref></p>
        <p>Dosing for olfacto-scintigraphy: 0.3 ml solution of thallium-201&#x000a0;(22MBq)&#x000a0;is administered nasally into the olfactory clefts, and 24 hours later, uptake of thallium-201 is evaluated with SPECT Scan. This test may correlate with CT, MRI, and T &#x00026; T olfactometry findings for further analysis.<xref ref-type="bibr" rid="article-30019.r25">[25]</xref><xref ref-type="bibr" rid="article-30019.r24">[24]</xref><xref ref-type="bibr" rid="article-30019.r23">[23]</xref></p>
      </sec>
      <sec id="article-30019.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Possible reported adverse effects of Thallium-201, when used for scintigraphy, include severe allergic reactions and gastrointestinal disturbances.<xref ref-type="bibr" rid="article-30019.r24">[24]</xref><xref ref-type="bibr" rid="article-30019.r25">[25]</xref>&#x000a0;Mustafa Yildirim et al. have demonstrated possible genetic damages with thallium-201 scans for myocardial perfusion imaging.<xref ref-type="bibr" rid="article-30019.r35">[35]</xref>&#x000a0;A study done to assess the effects of radiopharmaceuticals on testicular function showed a higher probability of ill-defined adverse effects with thallium-201 compared to Tc-99m.<xref ref-type="bibr" rid="article-30019.r36">[36]</xref>&#x000a0;Besides these adverse effects, there are some limitations to thallium-201 scans.</p>
        <p>Tc-based radiopharmaceuticals have largely replaced thallium-201 in myocardial perfusion imaging studies because of its longer half-life of 73 hrs (compared to Tc of 6 hrs) and its low-energy emission, which consequently needs a greater radiation dose but yields images of inferior quality than Tc scans.<xref ref-type="bibr" rid="article-30019.r37">[37]</xref><xref ref-type="bibr" rid="article-30019.r31">[31]</xref>&#x000a0;There have been no adverse effects reported with thallium-201 olfacto-scintigraphy.<xref ref-type="bibr" rid="article-30019.r38">[38]</xref><xref ref-type="bibr" rid="article-30019.r23">[23]</xref><xref ref-type="bibr" rid="article-30019.r39">[39]</xref></p>
      </sec>
      <sec id="article-30019.s6" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>The usual dose of thallium-201 used for SPECT scans is small; thus, it is safe for use.<xref ref-type="bibr" rid="article-30019.r2">[2]</xref>&#x000a0;However, some considerations are necessary for certain populations.&#x000a0;The recommendation is that lactating mothers should discontinue breastfeeding after a thallium-201 scan because it is excreted in breast milk. The exact time for discontinuation is still debatable, but a period of 2 weeks has been suggested by a study as the optimum period.</p>
        <p>Different studies have shown that the mother can pump breast milk before the procedure and freeze it for storage. After the scan, she can pump the breast milk and either throw it away or freeze it for about 30 days before use. Another option is to measure the radioactivity level of breast milk before commencing breastfeeding again to ensure safety.<xref ref-type="bibr" rid="article-30019.r40">[40]</xref>&#x000a0;A study done to assess the maternal-fetal transfer of thallium-201 in rats showed significant retention in organs of the mother as well as the fetus.<xref ref-type="bibr" rid="article-30019.r41">[41]</xref></p>
      </sec>
      <sec id="article-30019.s7" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>At a significantly higher dose than that used in routine imaging, thallium-201 can potentially cause hair loss, gastrointestinal hemorrhage, and neurological symptoms. Death reportedly results at concentrations of about 2.8mg/kg.<xref ref-type="bibr" rid="article-30019.r29">[29]</xref>&#x000a0;The FDA has approved the use of Prussian Blue for the therapeutic removal of thallium-201.<xref ref-type="bibr" rid="article-30019.r42">[42]</xref> Lansoprazole has also been shown to be useful for this process, as demonstrated by studies done in mice and rabbits.<xref ref-type="bibr" rid="article-30019.r43">[43]</xref></p>
      </sec>
      <sec id="article-30019.s8" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Thallium-201 administration for scintigraphy&#x000a0;requires an interprofessional team of healthcare professionals involving clinicians in different fields,&#x000a0;nurses, laboratory technicians, and specialized nuclear pharmacists. These various disciplines must coordinate their activities and engage in open communication regarding the patient's case to achieve the best diagnostic results and prevent any possible adverse events. [Level 5]</p>
        <p>Patients undergoing MPI should be advised to fast for a minimum of 4 hours before the scan.<xref ref-type="bibr" rid="article-30019.r1">[1]</xref>&#x000a0;It is advisable for patients undergoing nuclear myocardial scans with dipyridamole or adenosine to avoid caffeine for at least 24 hours.<xref ref-type="bibr" rid="article-30019.r44">[44]</xref>&#x000a0;Administration of thallium-201 must occur through a venous line abiding by the local radiation protocols.<xref ref-type="bibr" rid="article-30019.r45">[45]</xref>&#x000a0;</p>
        <p>Any article over the thorax that might have the potential to attenuate the image requires removal. Before initiating the scan, detailed cardiopulmonary history and examination are necessary.<xref ref-type="bibr" rid="article-30019.r1">[1]</xref>&#x000a0;Qualified health professional supervision is a requirement during the stress test. Equipment and drugs needed for cardiac life support must be present within reach of the certified professional at all times. The patient's condition during the procedure must be monitored continuously with EKG and vitals measurement. The handling of all the necessary equipment, radiopharmaceutical agents, and waste must follow standard protocols and guidelines from the respective authorities and the state.<xref ref-type="bibr" rid="article-30019.r1">[1]</xref>&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-30019.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30019&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30019">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30019/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30019">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-30019.s10">
        <title>References</title>
        <ref id="article-30019.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauss</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Wittry</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Cerqueira</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Iskandrian</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Schelbert</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Wackers</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Balon</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Machac</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Procedure guideline for myocardial perfusion imaging 3.3.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>155</fpage>
            <page-range>155-61</page-range>
            <pub-id pub-id-type="pmid">18703619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McKillop</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Thallium 201 scintigraphy.</article-title>
            <source>West J Med</source>
            <year>1980</year>
            <month>Jul</month>
            <volume>133</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-43</page-range>
            <pub-id pub-id-type="pmid">7222645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brindis</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Hendel</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Wolk</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Raskin</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Hendel</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Cerqueira</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Gibbons</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Gillam</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Gillespie</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hendel</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Iskandrian</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Jerome</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Krumholz</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Messer</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Spertus</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Stowers</surname>
                <given-names>SA</given-names>
              </name>
              <collab>American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group</collab>
              <collab>American Society of Nuclear Cardiology</collab>
              <collab>American Heart Association</collab>
            </person-group>
            <article-title>ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2005</year>
            <month>Oct</month>
            <day>18</day>
            <volume>46</volume>
            <issue>8</issue>
            <fpage>1587</fpage>
            <page-range>1587-605</page-range>
            <pub-id pub-id-type="pmid">16226194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fathala</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Myocardial perfusion scintigraphy: techniques, interpretation, indications and reporting.</article-title>
            <source>Ann Saudi Med</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>625</fpage>
            <page-range>625-34</page-range>
            <pub-id pub-id-type="pmid">22048510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malhotra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Doukky</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Assessment of myocardial viability using single-photon emission computed tomography myocardial perfusion imaging.</article-title>
            <source>Curr Opin Cardiol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>473</fpage>
            <page-range>473-483</page-range>
            <pub-id pub-id-type="pmid">31219878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mastrocola</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Amorim</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Vitola</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Brand&#x000e3;o</surname>
                <given-names>SCS</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>RSL</given-names>
              </name>
              <name>
                <surname>Lopes</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Chalela</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Carreira</surname>
                <given-names>LCTF</given-names>
              </name>
              <name>
                <surname>Ara&#x000fa;jo</surname>
                <given-names>JRN</given-names>
              </name>
              <name>
                <surname>Mesquita</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Meneghetti</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Update of the Brazilian Guideline on Nuclear Cardiology - 2020.</article-title>
            <source>Arq Bras Cardiol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>114</volume>
            <issue>2</issue>
            <fpage>325</fpage>
            <page-range>325-429</page-range>
            <pub-id pub-id-type="pmid">32215507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kailasnath</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sinusas</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201?</article-title>
            <source>Cardiol Rev</source>
            <year>2001</year>
            <season>May-Jun</season>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-72</page-range>
            <pub-id pub-id-type="pmid">11304401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beller</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Holzgrefe</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Effects of dipyridamole-induced vasodilation on myocardial uptake and clearance kinetics of thallium-201.</article-title>
            <source>Circulation</source>
            <year>1983</year>
            <month>Dec</month>
            <volume>68</volume>
            <issue>6</issue>
            <fpage>1328</fpage>
            <page-range>1328-38</page-range>
            <pub-id pub-id-type="pmid">6640881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giordano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marozzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Meduri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ficola</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Calcagni</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Vaccaro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rubini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Attard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li Puma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Corsello</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.</article-title>
            <source>Eur J Nucl Med</source>
            <year>1999</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>8</issue>
            <fpage>907</fpage>
            <page-range>907-11</page-range>
            <pub-id pub-id-type="pmid">10436206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacFarlane</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Hanelin</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Taft</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fredlund</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Localization of abnormal parathyroid glands using thallium-201.</article-title>
            <source>Am J Surg</source>
            <year>1984</year>
            <month>Jul</month>
            <volume>148</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-13</page-range>
            <pub-id pub-id-type="pmid">6742331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chou</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Sheen-Chen</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Preoperative localisation of parathyroid glands in primary hyperparathyroidism.</article-title>
            <source>Eur J Surg</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>163</volume>
            <issue>12</issue>
            <fpage>889</fpage>
            <page-range>889-95</page-range>
            <pub-id pub-id-type="pmid">9449440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhansali</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Masoodi</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Bhadada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Behra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison with radionuclide scintigraphy and surgery.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>65</volume>
            <issue>3</issue>
            <fpage>340</fpage>
            <page-range>340-5</page-range>
            <pub-id pub-id-type="pmid">16918953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wakamatsu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Noguchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamashita</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tamura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jinnouchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nagamachi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Futami</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.</article-title>
            <source>Eur J Nucl Med</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>1817</fpage>
            <page-range>1817-27</page-range>
            <pub-id pub-id-type="pmid">11734921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sekiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Akakura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mikami</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mizoguchi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tobe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Numata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Konno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of diagnostic imaging in primary hyperparathyroidism.</article-title>
            <source>Int J Urol</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-11; discussion 12</page-range>
            <pub-id pub-id-type="pmid">12534918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hussain</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Clinical Utility of Thallium-201 Single Photon Emission Computed Tomography and Cerebrospinal Fluid Epstein-Barr Virus Detection Using Polymerase Chain Reaction in the Diagnosis of AIDS-Related Primary Central Nervous System Lymphoma.</article-title>
            <source>Cureus</source>
            <year>2016</year>
            <month>May</month>
            <day>10</day>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>e606</fpage>
            <pub-id pub-id-type="pmid">27330874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antinori</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Rossi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ammassari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cingolani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Murri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Di Giuda</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>De Luca</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pierconti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tartaglione</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Scerrati</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Larocca</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Ortona</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma.</article-title>
            <source>J Clin Oncol</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>554</fpage>
            <page-range>554-60</page-range>
            <pub-id pub-id-type="pmid">10080599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giancola</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Rizzi</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Schiavo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lorenzini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schinin&#x000e0;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Alba</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Del Grosso</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gigli</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rosati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mango</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bibbolino</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Antinori</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Reduced value of thallium-201 single-photon emission computed tomography in the management of HIV-related focal brain lesions in the era of highly active antiretroviral therapy.</article-title>
            <source>AIDS Res Hum Retroviruses</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>584</fpage>
            <page-range>584-8</page-range>
            <pub-id pub-id-type="pmid">15242533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Knapp-Wachsner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hsieh</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Kamangar</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Kaposi Sarcoma without Mucocutaneous Involvement: The Role of Sequential Thallium and Gallium Scintigraphy.</article-title>
            <source>J Clin Imaging Sci</source>
            <year>2019</year>
            <volume>9</volume>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">31448163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>VW</given-names>
              </name>
              <name>
                <surname>Fuller</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Cooley</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Liebman</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning.</article-title>
            <source>Radiology</source>
            <year>1991</year>
            <month>Aug</month>
            <volume>180</volume>
            <issue>2</issue>
            <fpage>409</fpage>
            <page-range>409-12</page-range>
            <pub-id pub-id-type="pmid">2068302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kubo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimose</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fujimori</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Furuta</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ochi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Quantitative (201)thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis.</article-title>
            <source>Surg Oncol</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>194</fpage>
            <page-range>194-9</page-range>
            <pub-id pub-id-type="pmid">26092710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maria</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Drane</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Mastin</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Comparative value of thallium and glucose SPECT imaging in childhood brain tumors.</article-title>
            <source>Pediatr Neurol</source>
            <year>1998</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>351</fpage>
            <page-range>351-7</page-range>
            <pub-id pub-id-type="pmid">9880139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howman-Giles</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uren</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Thallium-201 scintigraphy in pediatric soft-tissue tumors.</article-title>
            <source>J Nucl Med</source>
            <year>1995</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>8</issue>
            <fpage>1372</fpage>
            <page-range>1372-6</page-range>
            <pub-id pub-id-type="pmid">7629580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Taki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Washiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Amano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Matsuura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tatsutomi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yagi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yoshizaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kinuya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miwa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of the olfactory nerve transport function by SPECT-MRI fusion image with nasal thallium-201 administration.</article-title>
            <source>Mol Imaging Biol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>1262</fpage>
            <page-range>1262-6</page-range>
            <pub-id pub-id-type="pmid">21136183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Taki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tonami</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kinuya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miwa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection.</article-title>
            <source>Int Forum Allergy Rhinol</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>9</volume>
            <issue>11</issue>
            <fpage>1252</fpage>
            <page-range>1252-1256</page-range>
            <pub-id pub-id-type="pmid">31356735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Taki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Washiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kinase</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kinuya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tonami</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Koshida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Amano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miwa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Assessment of olfactory nerve by SPECT-MRI image with nasal thallium-201 administration in patients with olfactory impairments in comparison to healthy volunteers.</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>e57671</fpage>
            <pub-id pub-id-type="pmid">23469046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kinoshita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shiga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Washiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Amano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsukatani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Miwa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Thallium transport and the evaluation of olfactory nerve connectivity between the nasal cavity and olfactory bulb.</article-title>
            <source>Chem Senses</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-8</page-range>
            <pub-id pub-id-type="pmid">17905744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iida</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kasagi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Misaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Arai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tokuda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Konishi</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Visualization of suppressed normal thyroid tissue by thallium-201 in patients with toxic nodular goiter.</article-title>
            <source>Clin Nucl Med</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>283</fpage>
            <page-range>283-5</page-range>
            <pub-id pub-id-type="pmid">3370895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erdil</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Onsel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kanmaz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Caner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>S&#x000f6;nmezo&#x0011f;lu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cift&#x000e7;i</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Turo&#x0011f;lu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kabasakal</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sayman</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Uslu</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Comparison of 99mTc-methoxyisobutyl isonitrile and 201T1 scintigraphy in visualization of suppressed thyroid tissue.</article-title>
            <source>J Nucl Med</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>41</volume>
            <issue>7</issue>
            <fpage>1163</fpage>
            <page-range>1163-7</page-range>
            <pub-id pub-id-type="pmid">10914905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradley-Moore</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Lebowitz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Atkins</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Ansari</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Thallium-201 for medical use. II: Biologic behavior.</article-title>
            <source>J Nucl Med</source>
            <year>1975</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>156</fpage>
            <page-range>156-60</page-range>
            <pub-id pub-id-type="pmid">1110422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henzlova</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Duvall</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Einstein</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Travin</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Verberne</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.</article-title>
            <source>J Nucl Cardiol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>606</fpage>
            <page-range>606-39</page-range>
            <pub-id pub-id-type="pmid">26914678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bedn&#x000e1;rov&#x000e1;</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kincl</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kam&#x000ed;nek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Va&#x00161;ina</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Panovsk&#x000fd;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>M&#x000e1;chal</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The prognostic value of ultra low-dose thallium myocardial perfusion protocol using CZT SPECT.</article-title>
            <source>Int J Cardiovasc Imaging</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>1163</fpage>
            <page-range>1163-1167</page-range>
            <pub-id pub-id-type="pmid">30680654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharir</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Slomka</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Dual-isotope myocardial perfusion SPECT imaging: Past, present, and future.</article-title>
            <source>J Nucl Cardiol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>2024</fpage>
            <page-range>2024-2028</page-range>
            <pub-id pub-id-type="pmid">28664393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishihara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taniguchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Onoguchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shibutani</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Optimal thallium-201 dose in cadmium-zinc-telluride SPECT myocardial perfusion imaging.</article-title>
            <source>J Nucl Cardiol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>947</fpage>
            <page-range>947-954</page-range>
            <pub-id pub-id-type="pmid">28008559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Thallium-201 is comparable to technetium-99m-sestamibi for estimating cardiac function in&#x000a0;patients with abnormal myocardial perfusion imaging.</article-title>
            <source>Kaohsiung J Med Sci</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>31</volume>
            <issue>11</issue>
            <fpage>562</fpage>
            <page-range>562-7</page-range>
            <pub-id pub-id-type="pmid">26678935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yildirim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ikbal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Seven</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pirim</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Varoglu</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Genotoxicity of thallium-201 in patients with angina pectoris undergoing myocardial perfusion study.</article-title>
            <source>Tohoku J Exp Med</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>206</volume>
            <issue>4</issue>
            <fpage>299</fpage>
            <page-range>299-304</page-range>
            <pub-id pub-id-type="pmid">15997200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manetou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Limouris</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Effects in the testes after SPECT myocardial perfusion with Tl-201 or Tc-99m hexaMIBI.</article-title>
            <source>Anticancer Res</source>
            <year>1997</year>
            <season>May-Jun</season>
            <volume>17</volume>
            <issue>3B</issue>
            <fpage>1841</fpage>
            <page-range>1841-4</page-range>
            <pub-id pub-id-type="pmid">9179242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Won</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>BI</given-names>
              </name>
            </person-group>
            <article-title>Recent trends in nuclear cardiology practice.</article-title>
            <source>Chonnam Med J</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>55</fpage>
            <page-range>55-64</page-range>
            <pub-id pub-id-type="pmid">24010067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Taki</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Okuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tonami</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kinuya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miwa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Prognostic value of olfactory nerve damage measured with thallium-based olfactory imaging in patients with idiopathic olfactory dysfunction.</article-title>
            <source>Sci Rep</source>
            <year>2017</year>
            <month>Jun</month>
            <day>15</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>3581</fpage>
            <pub-id pub-id-type="pmid">28620194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Washiyama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shiga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hirota</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yagi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoshizaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Furukawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Miwa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Biological safety of nasal thallium-201 administration: a preclinical study for olfacto-scintigraphy.</article-title>
            <source>J Radiat Res</source>
            <year>2011</year>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>450</fpage>
            <page-range>450-5</page-range>
            <pub-id pub-id-type="pmid">21905306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r40">
          <label>40</label>
          <element-citation publication-type="book">
            <chapter-title>Thallous Chloride Tl 201</chapter-title>
            <source>Drugs and Lactation Database (LactMed&#x000ae;) [Internet]</source>
            <publisher-name>National Institute of Child Health and Human Development</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2023</year>
            <month>10</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">29999756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rade</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Marafante</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sabbioni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gregotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Di Nucci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manzo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Placental transfer and retention of 201Ti-thallium in the rat.</article-title>
            <source>Toxicol Lett</source>
            <year>1982</year>
            <month>May</month>
            <volume>11</volume>
            <issue>3-4</issue>
            <fpage>275</fpage>
            <page-range>275-80</page-range>
            <pub-id pub-id-type="pmid">7101321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sandal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pathak</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Preparation, Characterization, and <italic>In Vivo</italic> Pharmacoscintigraphy Evaluation of an Intestinal Release Delivery System of Prussian Blue for Decorporation of Cesium and Thallium.</article-title>
            <source>J Drug Deliv</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>4875784</fpage>
            <pub-id pub-id-type="pmid">29318045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishad</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Rawat</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bhatnagar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Decorporation potential of lansoprazole against radiothallium (<sup>201</sup>Tl) in internally contaminated BALB/c mice and New Zealand White rabbits.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>106</fpage>
            <page-range>106-117</page-range>
            <pub-id pub-id-type="pmid">29909643</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powles</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Hessian</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Ruddy</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Practicing safe SPECT: caffeine abstinence in nuclear myocardial perfusion imaging.</article-title>
            <source>J Nucl Cardiol</source>
            <year>2008</year>
            <season>Sep-Oct</season>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>709</fpage>
            <page-range>709-18</page-range>
            <pub-id pub-id-type="pmid">18761274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30019.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anagnostopoulos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Harbinson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kelion</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kundley</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Loong</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Notghi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reyes</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tindale</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Underwood</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Procedure guidelines for radionuclide myocardial perfusion imaging.</article-title>
            <source>Heart</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>90 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>i1</fpage>
            <page-range>i1-10</page-range>
            <pub-id pub-id-type="pmid">14676223</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
